GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 78 days ( -8.68 % )
Last Price $99.99 0 %
High/ Low $99.99 - $99.99 0%
Chg 7 Days N/A $99.99 $99.99
Chg 30 Days N/A $99.99 $99.99
Chg 12 mos 61.48 % $61.92 $99.99
Trend - 3 mos 2.99 % Width: 5.65 %
Trend - 12 mos 73.19 % Width: 70.20 %
Pred. range - 3 mos $99.22 - $104.83 -0.765 % - 4.84 %
Pred. range - 12 mos $129.31 - $220.09 29.32 % - 120.11 %
Short MA avg 3 mos Buy 2022-03-07 - 59 days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2022-03-07 - 59 days
Long MA avg 12 mos Buy 2021-12-10 - 117 days
Short/Long MA avg 12 mos Buy 2021-12-13 - 116 days
Pivot Short Sell 2022-05-26 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Arena Pharmaceuticals

Arena Pharmaceuticals Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb c... ARNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT